Structure Features of Peptide-Type SARS-CoV Main Protease Inhibitors: Quantitative Structure Activity Relationship Study

27 April 2020, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

In the present work, an extensive QSAR (Quantitative Structure Activity Relationships) analysis of a series of peptide-type SARS-CoV main protease (MPro) inhibitors following the OECD guidelines has been accomplished. The analysis was aimed to identify salient and concealed structural features that govern the MPro inhibitory activity of peptide-type compounds. The QSAR analysis is based on a dataset of sixty-two peptide-type compounds which resulted in the generation of statistically robust and highly predictive multiple models. All the developed models were validated extensively and satisfy the threshold values for many statistical parameters (for e.g. R2 = 0.80–0.82, Q2loo = 0.74–0.77). The developed models identified interrelations of atom pairs as important molecular descriptors. Therefore, the present QSAR models have a good balance of Qualitative and Quantitative approaches, thereby, useful for future modifications of peptide-type compounds for anti- SARS-CoV activity.

Keywords

QSAR
COVID-19
SARS-CoV
Peptide-type Compounds

Supplementary materials

Title
Description
Actions
Title
Descriptors for submission-Ki
Description
Actions
Title
Supplementary material-Ki-Manuscript
Description
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.